Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine

Colorectal cancer is the third most common and the fourth most lethal cancer worldwide. In most of cases, patients are diagnosed at an advanced or even metastatic stage, thus explaining the high mortality. The lack of proper clinical tests and the complicated procedures currently used for detecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Anaïs, Boisvert, François-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313903/
https://www.ncbi.nlm.nih.gov/pubmed/30513835
http://dx.doi.org/10.3390/proteomes6040049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313903/
https://www.ncbi.nlm.nih.gov/pubmed/30513835
http://dx.doi.org/10.3390/proteomes6040049

Ejemplares similares